Consolidated Balance Sheets (Current Period Unaudited) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 3,988	$ 5,266
Accounts receivable, net	9,009	7,781
Inventories, net	2,747	2,816
Prepaid expenses and other current assets	2,226	2,525
Total current assets	17,970	18,388
Property and equipment, net	4,209	4,145
Intangible assets, net	8,637	8,968
Goodwill	18,948	18,948
Deferred tax asset	77	56
Other assets	141	147
TOTAL ASSETS	49,982	50,652
Current liabilities:
Accounts payable and accrued expenses	8,418	9,240
Deferred revenue	4,359	4,660
Short-term debt	1,578	1,532
Due to related parties	727	716
Current portion of pension liability	472	518
Deferred tax liability	260	271
Capital lease obligations	190	215
Total current liabilities	16,004	17,152
Pension liability	2,330	2,197
Deferred revenue	841	923
Long-term debt	763	772
Deferred tax liability	962	1,195
Other liabilities	628	686
Total liabilities	29,856	35,185
Commitments and contingencies
Shareholders' equity:
Preferred stock, par value $1.00, without designation Authorized - 1,000,000 shares, Issued - none	0	0
Common stock, par value $.01 Authorized - 150,000,000 shares Issued and outstanding - 34,059,219 at March 31, 2014 and 30,788,251 at December 31, 2013	341	308
Additional paid-in capital	111,469	103,642
Accumulated deficit	(91,485)	(88,243)
Accumulated other comprehensive loss	(405)	(421)
Total ChyronHego Corporation shareholders' equity	19,920	15,286
Non controlling interests	206	181
Total shareholders' equity	20,126	15,467
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	49,982	50,652
Fair Value, Inputs, Level 3 [Member]
Current liabilities:
Contingent consideration	$ 8,328	$ 12,260